Be part of the Pharmaceutical Industry’s Global Think Tank on SPCs and Patent Extensions

SPC continues to be at the forefront of product IP protection tool to extend its lifecycle. Article 3(a) has experienced further evolution through oral hearings at the ECJ  through C-650/17 QH (Royalty Pharma) and C-114/18 Sandoz vs. Searle. Additionally, this event will further explore the practical implementation of the EU Manufacturing Waiver and how it has impacted both innovator and generic market segments.

This exclusive gathering of leading in-house IP counsel, patent attorneys, representatives from multi-jurisdiction patent offices and policy authorities from around the globe who will share their insights on the complexities of SPCs and other types of patent extensions. They will provide you with comprehensive knowledge to ensure that you are leading the way in patent protection for your company and clients.

Sign up and stay tuned for more exciting programme announcement and our incredible speaker line-up!

KEEP ME NOTIFIED

Who Needs to Attend:

Pharmaceutical and Biotech Companies:

  • Global Patent Attorney
  • Patent Examiner
  • Head of Patent
  • Chief Patent Counsel
  • VP Patent Law
  • Patent & Legal Managers
  • Legal Director
  • Senior Counsel, Global Patents
  • Head of Intellectual Property Rights
  • Head of Patent Strategies & Litigation
  • Head of Legal

Private Practice Lawyers and Patent Attorneys specialising in:

  • IP and Patent Extensions

Register now and enjoy early bird savings!

Be part of an exclusive gathering of leading in-house IP counsel, patent attorneys, representatives from multi-jurisdiction patent offices and policy authorities from around the globe who will share their insights on the complexities of SPCs and other types of patent extensions. They will provide you with comprehensive knowledge to ensure that you are leading the way in patent protection for your company and clients.

REGISTER NOW

OUR PRIOR DELEGATES SAY IT BEST:

“I was pleasantly surprised by the content. There was less repetition than previous events; the general quality and variety of speakers was good and I certainly learned something.”   Robin Ellis Head of IP, Sandoz
“Good conference with international coverage from Europe as well as the rest of the world. Good and interesting speakers.”   Dorte Petersen, Senior Examiner, The Danish Patent and Trademark Office
“A great and info-rich conference.”   Ronnie Benshafrut Patent Attorney, Reinhold Cohn and Partners
“The conference was very interesting and very well organized; I enjoyed it a lot!”   Patent and Trademark Department Manager, Indena S.p.A.
“Interesting and challenging participants. I received questions that will help improving policy making and understanding of stakeholders’ perspective.”   Policy Officer, European Commission
Life Sciences Global Series Banner